UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2818-2825

1996

Volltextzugriff (PDF)

Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients

Cancer, 1999-07, Vol.86 (1), p.126-134

1999

Volltextzugriff (PDF)

Methods to detect P-glycoprotein-associated multidrug resistance in patients tumors : Consensus recommendations

Cancer research (Chicago, Ill.), 1996-07, Vol.56 (13), p.3010-3020

1996

Volltextzugriff (PDF)

A phase I study of irinotecan administered on a weekly schedule in pediatric patients

Pediatric Blood & Cancer, 2006-01, Vol.46 (1), p.50-55

2006

Volltextzugriff (PDF)

Phase I study of topotecan for pediatric patients with malignant solid tumors

Journal of clinical oncology, 1994-03, Vol.12 (3), p.539-543

1994

Volltextzugriff (PDF)

Low-grade astrocytoma with neuraxis dissemination at diagnosis

Journal of neurosurgery, 1995-07, Vol.83 (1), p.67-71

1995

Volltextzugriff (PDF)

Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (11), p.1554-1559

2014

Volltextzugriff (PDF)

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study

Journal of neuro-oncology, 1999-05, Vol.43 (1), p.43-47

1999

Volltextzugriff (PDF)

Supratentorial malignant gliomas in childhood : A single institution perspective

Cancer, 1997-08, Vol.80 (3), p.497-504

1997

Volltextzugriff (PDF)

Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors

Cancer chemotherapy and pharmacology, 1996, Vol.37 (3), p.195-202

1996

Volltextzugriff (PDF)

Triiodothyronine supplementation for hypothalamic obesity

Metabolism, clinical and experimental, 2002-11, Vol.51 (11), p.1381-1383

2002

Volltextzugriff (PDF)

Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer

Journal of pediatric hematology/oncology, 1999-05, Vol.21 (3), p.212-218

1999

Volltextzugriff (PDF)

P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma

Journal of clinical oncology, 1996-03, Vol.14 (3), p.886-900

1996

Volltextzugriff (PDF)

Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors

Journal of clinical oncology, 2004-06, Vol.22 (12), p.2445-2451

2004

Volltextzugriff (PDF)

Multidrug resistance in pediatric oncology

Investigational new drugs, 1996-01, Vol.14 (1), p.55-67

Kuttesch, Jr, J F

1996

Volltextzugriff (PDF)

Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells

Molecular pharmacology, 1993-09, Vol.44 (3), p.552-559

1993

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Thalidomide With Carboplatin in Children With Cancer

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4394-4400

2004

Volltextzugriff (PDF)

High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas

Journal of clinical oncology, 1993-08, Vol.11 (8), p.1458-1465

1993

Volltextzugriff (PDF)

Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998

Neuro-oncology (Charlottesville, Va.), 2001-07, Vol.3 (3), p.167-173

2001

Volltextzugriff (PDF)

Embryonal malignancies of unknown primary origin in children

Cancer, 1995-01, Vol.75 (1), p.115-121

1995

Volltextzugriff (PDF)

Phase I Evaluation of Oral and Intravenous Vinorelbine in Pediatric Cancer Patients: A Report from the Children's Oncology Group

Clinical cancer research, 2006-01, Vol.12 (2), p.516-522

2006

Volltextzugriff (PDF)

Advances and controversies in the management of childhood brain tumors

Current opinion in oncology, 1997-05, Vol.9 (3), p.235-240

Kuttesch, John F

1997

Volltextzugriff (PDF)

Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center

International journal of radiation oncology, biology, physics, 2002-03, Vol.52 (4), p.1008-1016

2002

Volltextzugriff (PDF)

Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea

Molecular pharmacology, 1994-05, Vol.45 (5), p.962-970

1994

Volltextzugriff (PDF)

Neurological symptoms associated with cyclosporin plus doxorubicin

The Lancet (British edition), 1992-08, Vol.340 (8817), p.496-496

1992

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(64)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas

Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients

Methods to detect P-glycoprotein-associated multidrug resistance in patients tumors : Consensus recommendations

A phase I study of irinotecan administered on a weekly schedule in pediatric patients

Phase I study of topotecan for pediatric patients with malignant solid tumors

Low-grade astrocytoma with neuraxis dissemination at diagnosis

Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study

Supratentorial malignant gliomas in childhood : A single institution perspective

Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors

Triiodothyronine supplementation for hypothalamic obesity

Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer

P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma

Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors

Multidrug resistance in pediatric oncology

Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cells

Phase I and Pharmacokinetic Study of Thalidomide With Carboplatin in Children With Cancer

High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas

Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998

Embryonal malignancies of unknown primary origin in children

Phase I Evaluation of Oral and Intravenous Vinorelbine in Pediatric Cancer Patients: A Report from the Children's Oncology Group

Advances and controversies in the management of childhood brain tumors

Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center

Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea

Neurological symptoms associated with cyclosporin plus doxorubicin

Suchergebnisse filtern